Nachricht
***********************************************************
| Weitere ausführliche Terminübersichten erhalten Sie unter: | |
| * POLITIK/VERMISCHTES | |
* KONJUNKTUR/GELDPOLITIK
Alle Zeitangaben in Central European Time (CET)
SGS 2024 Q3 Sales Update
05:00 - Sika Q3 results
05:30 - Remy Cointreau H1 2024/25 sales
06:30 - HOLCIM Q3 Sales
06:55 - Stratec Q3 results
07:00 - Mercedes-Benz publishes third quarter results Mercedes-Benz, which cut its annual outlook in September, publishes third-quarter results.
07:30 - Q3 2024 Sanofi Earnings Release Sanofi third-quarters results are likely driven by wider use of anti-inflammation drug Dupixent, haemophilia drug Altuviiio, Beyfortus to prevent infant infections and Tzield for type one diabetes. There could also be an update on plans to sell or list the Opella consumer health business.
08:30 - Q3 2024 Stratec SE Earnings Release
17:30 - Porsche publishes third quarter results
18:30 - US appeals court weighs whether to uphold Elon Musk's victory in Tesla 'funding secured' tweet case A U.S. appeals court will consider whether to uphold a jury's verdict finding Tesla CEO Elon Musk and his company not liable for misleading investors when the billionare tweeted in 2018 that he had "funding secured" to take the electric car company private. The case is before the 9th U.S. Circuit Court of Appeals in San Francisco.